ViewMate Multi Ultrasound System (VMM-ICE-01); ViewMate Multi Ultrasound System (VMM-ICE-02)
K251250 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · IYN · Sep 5, 2025 · Radiology
Device Facts
| Record ID | K251250 |
| Device Name | ViewMate Multi Ultrasound System (VMM-ICE-01); ViewMate Multi Ultrasound System (VMM-ICE-02) |
| Applicant | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. |
| Product Code | IYN · Radiology |
| Decision Date | Sep 5, 2025 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1550 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Intended Use
This device is a general purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid, which is intended to be used in a hospital or medical clinic. VMM-ICE-01/VMM-ICE-02 ViewMate™ Multi Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in Abdominal, Intraoperative (abdominal, thoracic, and vascular), Pediatric, Small Organ (Thyroid, Breast, Testes), Neonatal Cephalic, Adult Cephalic, Musculo-skeletal (Conventional, Superficial), Cardiac Adult, Cardiac Pediatric, Trans-esoph. (Cardiac), Intra-cardiac, and Peripheral vessel exams. Modes of operation include: B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode (B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, TDI, Color M.
Device Story
General purpose, mobile, software-controlled ultrasonic diagnostic system. Inputs: ultrasonic echoes received via transducers. Operation: transmits ultrasonic energy into patient; processes received echoes to generate real-time anatomical and fluid flow images. Outputs: onscreen display of structures, measurements, and analysis packages. Used in hospitals/clinics by qualified healthcare professionals. Features include EnSite X connectivity for data transmission to external EP systems and V1/V2 velocity ratio measurement. Output assists clinicians in diagnosis and anatomical assessment. Benefits: non-invasive diagnostic imaging and measurement.
Clinical Evidence
No clinical data. Substantial equivalence supported by bench testing, including acoustic output measurements (NEMA UD 2-2004), electrical safety (ANSI AAMI ES60601-1), electromagnetic compatibility (IEC 60601-1-2), usability (IEC 60601-1-6, IEC 62366-1), and software lifecycle processes (IEC 62304).
Technological Characteristics
Mobile ultrasonic pulsed Doppler/echo imaging system. Materials: patient-contact materials identical to predicate. Energy: ultrasonic. Connectivity: supports data export to external EP systems (EnSite X). Software: version 02. Standards: NEMA UD 2-2004, IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-1, ISO 14971, IEC 62304.
Indications for Use
Indicated for adults, pregnant women, pediatric patients, and neonates for ultrasound imaging, measurement, and analysis in abdominal, intraoperative, pediatric, small organ, cephalic, musculoskeletal, cardiac, and peripheral vessel exams.
Regulatory Classification
Identification
An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Predicate Devices
Reference Devices
- Abbott Ensite™ X EP system (K251234)
- P9-3icSE transducer (K251231)
Related Devices
- K222754 — ViewMate Multi Ultrasound System · Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. · Nov 9, 2022
- K240684 — Resona I9, Resona I9 Exp, Resona I9S, Resona I9T, Resona I9 Easi, Resona I9 Nasa, Resona IV, Imagyn I9, Imagyn I9S, Imagyn I9 Easi, Nuewa I9, Nuewa I9S, Nuewa I9T, Nuewa I9 Exp, Nuewa I9 Easi, Anesus I9, Anesus I9 Easi, Eagus I9, Resona I9W, Recho I9, Recho I9 Pro, Recho I9 Exp, Recho I9S, Recho I9T Diagnostic Ultrasound System · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 17, 2024
- K251853 — Consona N5, Consona N5 Pro, Consona N5 Super, Consona N5 Exp, Consona ER, Consona N5S, Consona EI, Consona EF, Consona N5 Elite, Consona N5 Ultra, Consona N3, Consona N3 Exp Diagnostic Ultrasound System · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Nov 7, 2025
- K152763 — Resona 7/Resona 7CV/Resona 7EXP/Resona 7S/Resona 7OB Diagnostic Ultrasound System · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 21, 2015
- K250020 — Diagnostic Ultrasound System (Recho R9W); Diagnostic Ultrasound System (Recho R9); Diagnostic Ultrasound System (Recho R9 Pro); Diagnostic Ultrasound System (Recho R9 Exp); Diagnostic Ultrasound System (Recho R9S); Diagnostic Ultrasound System (Recho R9T); Diagnostic Ultrasound System (Crius R9 CV); Diagnostic Ultrasound System (Anesus R9 CV); Diagnostic Ultrasound System (Recho R9 Super); Diagnostic Ultrasound System (Recho R9 Lumi); Diagnostic Ultrasound System (Recho R CV); Diagnost · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · May 19, 2025
Submission Summary (Full Text)
{0}
FDA U.S. FOOD & DRUG ADMINISTRATION
September 05, 2025
Shenzhen Mindray Bio-medical Electronics Co., Ltd.
Xiaozhen Ding
Technical Regulatory Affairs
Mindray Building, Keji 12th Road South
Hi-tech Industrial Park, Nanshan
Shenzhen, Guangdong 518057
CHINA
Re: K251250
Trade/Device Name: ViewMate™ Multi Ultrasound System (VMM-ICE-01); ViewMate™ Multi Ultrasound System (VMM-ICE-02)
Regulation Number: 21 CFR 892.1550
Regulation Name: Ultrasonic Pulsed Doppler Imaging System
Regulatory Class: Class II
Product Code: IYN, IYO, ITX
Dated: August 6, 2025
Received: August 6, 2025
Dear Xiaozhen Ding:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{1}
K251250 - Xiaozhen Ding
Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
{2}
K251250 - Xiaozhen Ding
Page 3
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
MARJAN NABILI -S for
Yanna Kang, Ph.D.
Assistant Director
Mammography and Ultrasound Team
DHT8C: Division of Radiological
Imaging and Radiation Therapy Devices
OHT8: Office of Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{3}
ViewMateTM Multi Ultrasound System
Page 8 of 73
| Indications for Use | | |
| --- | --- | --- |
| Please type in the marketing application/submission number, if it is known. This
textbox will be left blank for original applications/submissions. | K251250 | ? |
| Please provide the device trade name(s). | | ? |
| ViewMate™ Multi Ultrasound System (VMM-ICE-01);
ViewMate™ Multi Ultrasound System (VMM-ICE-02) | | |
| Please provide your Indications for Use below. | | ? |
| This device is a general purpose diagnostic ultrasound system intended for use by qualified and
trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the
human body and fluid, which is intended to be used in a hospital or medical clinic.
VMM-ICE-01/VMM-ICE-02 ViewMateTM Multi Ultrasound System is applicable for adults,
pregnant women, pediatric patients and neonates. It is intended for use in Abdominal, Intraoperative
(abdominal, thoracic, and vascular), Pediatric, Small Organ (Thyroid, Breast, Testes),
Neonatal Cephalic, Adult Cephalic, Musculo-skeletal (Conventional, Superficial), Cardiac Adult,
Cardiac Pediatric, Trans-esoph. (Cardiac), Intra-cardiac, and Peripheral vessel exams.
Modes of operation include: B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined
mode (B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic
Imaging, TDI, Color M. | | |
| Please select the types of uses (select one or both, as
applicable). | ☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? |
{4}
Page 1 of 6
# 510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR § 80792(c).
The assigned 510(k) number: K251250
## 1. Submitter
Shenzhen Mindray Bio-medical Electronics Co., LTD
Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
Tel: +86 755 8188 6129
Fax: +86 755 2658 2680
## Contact Person
Xiaozhen Ding
Email: dingxiaozhen@mindray.com
Tel: 818-88321 Mobile: +86-17864159886
Shenzhen Mindray Bio-medical Electronics Co., LTD
Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
**Date Prepared**: April 19, 2025
## 2. Device Name
ViewMate™ Multi Ultrasound System (VMM-ICE-01)
ViewMate™ Multi Ultrasound System (VMM-ICE-02)
**Classification**
Regulatory Class: II
Review Category: Tier II
21 CFR 892.1550 Ultrasonic Pulsed Doppler Imaging System (IYN)
21 CFR 892.1560 Ultrasonic Pulsed Echo Imaging System (IYO)
21 CFR 892.1570 Diagnostic Ultrasound Transducer (ITX)
## 3. Predicate device
ViewMate™ Multi Ultrasound System is comparable with and substantially
{5}
equivalent to the predicate device listed below. VMM-ICE-01 (K222754) is the main predicate device.
| Device | Manufacturer | Model | 510(k) Number |
| --- | --- | --- | --- |
| 1. Main predicate device | Mindray | VMM-ICE-01 | K222754 |
The result shows the conformance of subject device to the predicate device.
Regulation name and code
21 CFR 892.1550 Ultrasonic Pulsed Dopple Imaging System (IYN)
21 CFR 892.1560 Ultrasonic Pulsed Echo Imaging System (IYO)
21 CFR 892.1570 Diagnostic Ultrasound Transducer (ITX)
## 4. Device Description:
The ViewMate™ Multi Ultrasound System is a general purpose, mobile, software controlled, ultrasonic diagnostic system.
The ViewMate™ Multi Ultrasound System can also measure anatomical structures and offer analysis packages to provide information based on which the competent health care professionals can make the diagnosis.
The ViewMate™ Multi Ultrasound System has two models: VMM-ICE-01, VMM-ICE-02.
Page 2 of 6
{6}
Page 3 of 6
## 5. Intended Use:
This device is a general purpose diagnostic ultrasound system intended for use by qualified and trained healthcare professionals for ultrasound imaging, measurement, display and analysis of the human body and fluid, which is intended to be used in a hospital or medical clinic.
VMM-ICE-01/VMM-ICE-02 ViewMate™ Multi Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in Abdominal, Intraoperative (abdominal, thoracic, and vascular), Pediatric, Small Organ (Thyroid, Breast, Testes), Neonatal Cephalic, Adult Cephalic, Musculoskeletal (Conventional, Superficial), Cardiac Adult, Cardiac Pediatric, Trans-esoph. (Cardiac), Intra-cardiac, and Peripheral vessel exams.
Modes of operation include: B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode (B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, TDI, Color M.
## 6. Comparison with Predicate Devices:
Subject device ViewMate™ Multi Ultrasound System is comparable with and substantially equivalent to the predicate device with regards to intended use, imaging modes, features and functions and technological characteristics.
All systems transmit ultrasonic energy into patients, perform post processing of received echoes to generate onscreen display of anatomic structures and fluid flow within the body. All systems allow for specialized measurements of structures and flow, as well as calculations.
Subject device ViewMate™ Multi Ultrasound System has the same intended uses as the predicate device VMM-ICE-01 (K222754).
The patient contact materials of the new transducers of subject device ViewMate™ Multi Ultrasound System are the same to the predicate device VMM-ICE-01 (K222754).
The acoustic power levels of ViewMate™ Multi Ultrasound System are below the FDA recommended levels, which are the same as the predicate device VMM-ICE-01 (K222754).
ViewMate™ Multi Ultrasound System is designed in compliance with the FDA recognized electrical and physical safety standards, which are the same as the predicate device VMM-ICE-01 (K222754).
## For the differences compared to the predicate device:
New special options introduced to the ViewMate™ Multi series, which in the below that either the improvements or enhancement based on the cleared functions to
{7}
facilitate user, no new intended uses are added and passed the related tests, no clinical risks introduced.
| Subject Device | Function explanation |
| --- | --- |
| EnSite X | The EnSite X can support ultrasound systems sending ultrasound data to Abbott Ensite™ X EP system (cleared under K251234). |
| V1/V2 | The V1/V2 can measurement of the velocity ratio at any two points on an ultrasound spectral image. |
| Items | Subject DeviceViewMate™ Multi series | Predicate deviceVMM-ICE-01 (K222754) | S/D |
| --- | --- | --- | --- |
| Indications for use | ViewMate™ Multi Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in Abdominal, Intra-operative (abdominal, thoracic, and vascular), Pediatric, Small Organ (Thyroid, Breast, Testes), Neonatal Cephalic, Adult Cephalic, Musculo-skeletal (Conventional, Superficial), Cardiac Adult, Cardiac Pediatric, Trans-esoph. (Cardiac), Intra-cardiac, and Peripheral vessel exams. | ViewMate™ Multi Ultrasound System is applicable for adults, pregnant women, pediatric patients and neonates. It is intended for use in Abdominal, Intra-operative (abdominal, thoracic, and vascular), Pediatric, Small Organ (Thyroid, Breast, Testes), Neonatal Cephalic, Adult Cephalic, Musculo-skeletal (Conventional, Superficial), Cardiac Adult, Cardiac Pediatric, Trans-esoph. (Cardiac), Intra-cardiac, and Peripheral vessel exams. | S |
| Modes of operation | B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode(B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, TDI, Color M. | B, M, PWD, CWD, Color Doppler, Amplitude Doppler, Combined mode(B+M, PW+B, Color+B, Power+B, PW+Color+B, Power+PW+B), Tissue Harmonic Imaging, TDI, Color M. | S |
| Software version | 02 | 01 | D |
| Model | VMM-ICE-01VMM-ICE-02 | VMM-ICE-01 | D |
| Software function (Ensite X) | ✓ | × | D |
| Software function (V1/V2) | ✓ | × | D |
| Transducer (P9-3icSE cleared under K251231) | ✓ | × | D |
{8}
The differences between these models are shown as followed table:
| Model | V1/V2 (Velocity1/Velocity2) |
| --- | --- |
| VMM-ICE-01 | × |
| VMM-ICE-02 | √ |
According to the table, we can see that VMM-ICE-02 model consists of all available functions, compared with VMM-ICE-01, VMM-ICE-02 has V1/V2 function, other functions are same as VMM-ICE-01, including the Indications for Use, hardware/software platform and mechanical platform.
# 7. Non-clinical Tests:
ViewMate™ Multi Ultrasound System has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical and mechanical safety, and this device has been designed to conform with applicable medical safety standards.
This device has been tested and evaluated under the following standards:
NEMA UD 2-2004 (R2009), acoustic output measurement standard for diagnostic ultrasound equipment revision 3.
■ ANSI AAMI ES60601-1:2005/(R)2012 & A1:2012, C1:2009/(R)2012 & A2:2010/(R)2012 (Cons. Text) [Incl. AMD2:2021] Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) [Including Amendment 2 (2021)].
IEC 60601-1-2 Edition 4.1 2020-09 CONSOLIDATED VERSION, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests.
IEC TS 60601-4-2 Edition 1.0 2024-03 Medical electrical equipment - Part 4-2: Guidance and interpretation - Electromagnetic immunity: performance of medical electrical equipment and medical electrical systems
IEC 60601-1-6 Edition 3.2 2020-07 CONSOLIDATED VERSION, Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability.
IEC 60601-2-37 Edition 2.1 2015, Medical electrical equipment - Part 2-37: Particular requirements for the basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment.
ISO 14971 Third Edition 2019-12, Medical devices - Application of risk management to medical devices.
ISO 10993-1 Fifth edition 2018-08, biological evaluation of medical devices - part 1: evaluation and testing within a risk management process.
IEC 62304 Edition 1.1 2015-06 CONSOLIDATED VERSION, medical device software - software life cycle processes.
IEC 62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION, Medical devices -
{9}
Part 1: Application of usability engineering to medical devices.
These non-clinical tests relied on in this premarket notification submission can support the determination of substantial equivalence of the subject device.
## 8. Clinical Studies
Not applicable. The subject of this submission, ViewMate™ Multi Ultrasound System, does not require clinical studies to support substantial equivalence.
## 9. Summary
Based on the performance data as documented in the study, ViewMate™ Multi Ultrasound System was found to have a safety and effectiveness profile that is similar to the predicate device.
## 10. Conclusion:
Intended uses and other key features are consistent with traditional clinical practices, FDA guidelines and established methods of patient examination. The design, development and quality process of the manufacturer confirms with 21 CFR 820, ISO 9001 and ISO 13485 quality systems. The device conforms to applicable medical device safety standards. Therefore, the ViewMate™ Multi Ultrasound System is substantially equivalent with respect to safety and effectiveness to the predicate device.
Page 6 of 6